Click on a program title below to view the on-demand webcast. CME and/or CNE accreditation has expired for archived programs.

ASM 2016 screenshot

Predicting Infections in Transplant Patients: Cellular Immune Assays for Tuberculosis and CMV

This program is intended for physicians, scientists, nurses, microbiologists, and pharmacists who are interested in the clinical and research aspects of microbiology and its applications in solid organ and tissue transplantation. It reviews the importance of screening for TB in transplant patients and explores the use of cellular immune assays to identify patients at risk of developing CMV post-transplant. Clinical case studies are presented to discuss the use of this information as part of a patient's overall clinical picture.
  • Presented by:
  • Roy F. Chemaly, MD, MPH, FIDSA, FACP
  • Raymund R. Razonable, MD
IGRA Screenshot AOHC 2014

TST, IGRAs, and Occupational Health: Analyzing your Tuberculosis Testing Options

This program reviews the advantages and disadvantages of different TB testing methods in various clinical settings and the relative financial strengths and weaknesses of IGRAs and the TST, leading into a discussion of strategy for presenting a financial justification to switch from the TST to an IGRA.

Presented by:
  • Theodore Them, MD, MS, PhD, MPH, FACOEM
  • Chris Kadlecek, PT

Breaking Down Barriers in TB Screening for the Transplant Patient

This program provides a comprehensive overview for clinicians about how to evaluate all of the considerations that are associated with TB screening of both recipient and donor patients, and the impact of TB test results on clinical management before and after transplant.
Presented by:
  • Camille Nelson Kotton, MD, FIDSA
  • Deepali Kumar, MD, MSc, FRCPC
  • Prof. Dr. Martina Sester, PhD
Igra screenshot Dayvault 2014 2

From Ordinary to Extraordinary: Reinventing the TB Screening Process

This program provides a comprehensive overview for nurses about how to evaluate all of the considerations that are associated with TB testing (cost, logistics, test performance) to appropriately determine the best test for their institution and employees.
Presented by:
  • Kathy Dayvault, RN, BSN, MPH, COHN-S/CM
IDWeek 2014 Screenshot

Update on IGRA Testing: Screening for Latent Tuberculosis in Children, Healthcare Workers, and Immunocompromised Patients

The goal of this activity is to convey information to infectious disease specialists and promote an active discussion on options in TB testing for various patient populations, including healthcare workers, immunocompromised patients, and pediatric patients.
Presented by:
  • Roy Chemaly, MD, MPH, FIDSA, FACP
  • Thomas C. King, MD, PhD
  • Anna Mandalakas, MD, MSEpi, FAAP
  • Theodore Them, MD, MS, PhD, MPH, FACOEM
ACR 2014 screenshot

Prevention and Management of Infections with Biologic Therapy: Do’s, Don’ts and Maybes

This program is intended for rheumatologists and other healthcare professionals treating patients with rheumatic diseases undergoing biologic therapy. The presentation aims to educate providers on the best screening methods for detecting LTBI in rheumatic patients and how to keep their patients safe from developing TB and other infections while receiving biologic therapy.
Presented by:
  • Leonard Calabrese, DO
  • Kevin Winthrop, MD, MPH

Diagnosis and Treatment of Latent Tuberculosis in Children: What to Use and When

This program provides a comprehensive overview of updated recommendations on the diagnosis and treatment of latent tuberculosis infection (LTBI) in children. The presentation reviews the advantages and limitations of the tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) in the diagnosis of LTBI in pediatric patients.
Presented by:
  • Amina Ahmed, MD
  • Andrea T. Cruz, MD, MPH

Incorporating IGRA Testing into the Employee Health Medical Surveillance Program

The goal of this activity is to educate nurses about how to evaluate all of the considerations that are associated with TB testing (cost, logistics, test performance) to appropriately determine the best test for their institution and employees. The target audience of this program are occupational health and employee health professionals involved in the regular screening of employees for Latent Tuberculosis Infection (LTBI).

Presented by:
  • Marcie DeWitt, MSN, APRN, FNP-C
igra Chemaly Screenshot 2015 final

The Challenges and Pitfalls in Diagnosing or Misdiagnosing Tuberculosis in Transplant Recipients

The goal of this activity is to convey information to physicians and health care professionals in the field of transplantation and to encourage group participation and discussion. At the end of this activity, participants should be able to determine the epidemiology and incidence of TB infection in immunocompromised patients, differentiate between the 3 available latent TB testing methods, and identify the clinical utility of IGRAs when testing immunocompromised patients for TB.

Presented by:
  • Roy Chemaly, MD, MPH, FIDSA, FACP
 ACR 2015 TB On demand

The Challenge of Mycobacterial Infections in the Biologic Era

This program is intended for rheumatologists and other healthcare professionals treating patients with rheumatic diseases and opportunistic infections in the biological setting. At the end of this activity, participants should be able to manage complex case scenarios of opportunistic infections in rheumatic disease patients and discuss appropriate clinical management of patients who develop infections during therapy.

Presented by:
  • Juzar Ali, MD, FRCP, FCCP(C)
  • Leonard Calabrese, DO
  • Kevin Winthrop, MD, MPH
IUATLD NAR 2016

Diabetes & Tuberculosis: Converging Epidemics and Their Impact on Patient Care

This program, recorded at the Joint 20th Annual Conference of The Union North America Region and the National TB Controllers Association), reviews the detrimental relationship between tuberculosis and diabetes mellitus, and its implications for patient screening, treatment and outcomes. The challenges of coordinating care for patients suffering from both TB and diabetes, and sample case studies, are discussed as well.
  • Presented by:
  • Megan Murray, MD, MPH, ScD
  • Juzar Ali, MD, FRCP, FCCP(C)
  • Gayatri Mirani , MD
ATC 2016

Predicting Infections in Transplant Patients: Cellular Immune Assays for Tuberculosis and CMV

This program is intended for physicians, surgeons, scientists, nurses, organ procurement personnel, and pharmacists who are interested in the clinical and research aspects of solid organ and tissue transplantation. It reviews the importance of screening for TB in transplant patients and explores the use of cellular immune assays to identify patients at risk of developing CMV post-transplant. Clinical case studies are presented to discuss the use of this information as part of a patient's overall clinical picture.
  • Presented by:
  • Roy F. Chemaly, MD, MPH, FIDSA, FACP
  • Camille Nelson Kotton, MD, FIDSA
Back to Top